Computational Model of the HIV-1 Subtype A V3 Loop: Study on the Conformational Mobility for Structure-Based Anti-AIDS Drug Design
暂无分享,去创建一个
[1] R F Standaert,et al. Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex , 1991, Science.
[2] Pengyu Y. Ren,et al. Polarizable Atomic Multipole Water Model for Molecular Mechanics Simulation , 2003 .
[3] Michael M. Endrich,et al. The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood. , 1998, European journal of biochemistry.
[4] J. Davide,et al. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. , 1990, Science.
[5] A. Andrianov. Study on conformational homology of the HIV-1 gp120 protein V3 loop. Structural analysis of the HIV-RF and HIV-thailand viral strains , 2007 .
[6] A. Andrianov,et al. Immunophilins and HIV-1 V3 Loop For Structure-Based Anti-AIDS Drug Design , 2009, Journal of biomolecular structure & dynamics.
[7] D. van der Spoel,et al. GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .
[8] Oliver Hartley,et al. V3: HIV's switch-hitter. , 2005, AIDS research and human retroviruses.
[9] A. Andrianov. Computational Anti-AIDS Drug Design Based on the Analysis of the Specific Interactions Between Immunophilins and the HIV-1 gp120 V3 Loop. Application to the FK506-Binding Protein , 2008, Journal of biomolecular structure & dynamics.
[10] Stephen Taylor,et al. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization. , 2005, Journal of molecular biology.
[11] K. Chou,et al. Glycosylation of HIV-1 gp120 V3 loop: towards the rational design of a synthetic carbohydrate vaccine. , 2007, Current medicinal chemistry.
[12] Reed J. Harris,et al. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. , 1990, The Journal of biological chemistry.
[13] H. Berendsen,et al. Interaction Models for Water in Relation to Protein Hydration , 1981 .
[14] Structure and Polymorphism of the Principal Neutralization Site of Thailand HIV-1 Isolate , 2003, Journal of biomolecular structure & dynamics.
[15] K. Kopple,et al. Reverse Turns in Peptides and Protein , 1980 .
[16] Adeeba Kamarulzaman,et al. AIDS Res Hum Retroviruses , 2006 .
[17] David Yang,et al. The N-Terminal V3 Loop Glycan Modulates the Interaction of Clade A and B Human Immunodeficiency Virus Type 1 Envelopes with CD4 and Chemokine Receptors , 2000, Journal of Virology.
[18] H. Dyson,et al. Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120. , 1991, Biochemistry.
[19] Kuo-Chen Chou,et al. HIV-1 gp120 V3 loop for structure-based drug design. , 2005, Current protein & peptide science.
[20] N. Guex,et al. SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.
[21] Roland L. Dunbrack,et al. Backbone-dependent rotamer library for proteins. Application to side-chain prediction. , 1993, Journal of molecular biology.
[22] P. Auewarakul,et al. N-linked glycosylation in C2 region of HIV-1 envelope reduces sensitivity to neutralizing antibodies. , 2005, Viral immunology.
[23] V. Veresov,et al. Determination of structurally conservative amino acids of the HIV-1 protein gp120 V3 loop as promising targets for drug design by protein engineering approaches , 2006, Biochemistry (Moscow).
[24] J. Morris,et al. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. , 1991, AIDS research and human retroviruses.
[25] Characteristics of HIV-1 env V3 loop sequences for subtype A1 variant spread in Eastern Europe. , 2005, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[26] Global and local structural properties of the principal neutralizing determinant of the HIV-1 envelope protein gp120. , 1999, Journal of biomolecular structure & dynamics.
[27] L. Stamatatos,et al. N-Linked Glycosylation of the V3 Loop and the Immunologically Silent Face of gp120 Protects Human Immunodeficiency Virus Type 1 SF162 from Neutralization by Anti-gp120 and Anti-gp41 Antibodies , 2004, Journal of Virology.
[28] I. Wilson,et al. Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop. , 2003, Virology.
[29] M. Cho,et al. N-Linked Glycosylation Sites Adjacent to and within the V1/V2 and the V3 Loops of Dualtropic Human Immunodeficiency Virus Type 1 Isolate DH12 gp120 Affect Coreceptor Usage and Cellular Tropism , 2001, Journal of Virology.
[30] P. Bisen,et al. HIV and AIDS:: Basic Elements and Priorities , 2007 .
[31] J. Riley,et al. A single point mutation in HIV-1 V3 loop alters the immunogenic properties of rgp120 , 2000, Archives of Virology.
[32] J M Thornton,et al. Analysis of main chain torsion angles in proteins: prediction of NMR coupling constants for native and random coil conformations. , 1996, Journal of molecular biology.
[33] I. Wilson,et al. Crystal structure of the principal neutralization site of HIV-1. , 1994, Science.
[34] Peter A. Kollman,et al. AMBER: Assisted model building with energy refinement. A general program for modeling molecules and their interactions , 1981 .
[35] Emmanuel G. Cormier,et al. The Crown and Stem of the V3 Loop Play Distinct Roles in Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Interactions with the CCR5 Coreceptor , 2002, Journal of Virology.
[36] Jaap Goudsmit,et al. N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization* , 2001, The Journal of Biological Chemistry.
[37] B. Meyer,et al. Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1. , 2001, Glycobiology.
[38] S. Zolla-Pazner,et al. A Highly Conserved Arginine in gp120 Governs HIV-1 Binding to Both Syndecans and CCR5 via Sulfated Motifs* , 2005, Journal of Biological Chemistry.
[39] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[40] K. Chou,et al. Simulated annealing approach to the study of protein structures. , 1991, Protein engineering.
[41] David W Ritchie,et al. Docking essential dynamics eigenstructures , 2005, Proteins.
[42] A. Andrianov,et al. Method of determining protein conformations by the two-dimensional nuclear Overhauser enhancement spectroscopy data. , 1987, Journal of biomolecular structure & dynamics.
[43] Chris Oostenbrink,et al. A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6 , 2004, J. Comput. Chem..
[44] P. Taylor,et al. X-Ray Structures and Analysis of 11 Cyclosporin Derivatives Complexed with Cyclophilin A. , 1998 .
[45] J. Goudsmit,et al. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution , 1992, Journal of virology.
[46] Local Structural Properties of the V3 Loop of Thailand HIV-1 Isolate , 2002, Journal of biomolecular structure & dynamics.
[47] A. Andrianov. Dual Spatial Folds and Different Local Structures of the HIV-1 Immunogenic Crown in Various Virus Isolates , 2004, Journal of biomolecular structure & dynamics.
[48] A. Andrianov. Determining the Invariant Structure Elements of the HIV-1 Variable V3 Loops: Insight into the HIV-MN and HIV-Haiti Isolates , 2008, Journal of biomolecular structure & dynamics.
[49] H. Scheraga,et al. Chain reversals in proteins. , 1973, Biochimica et biophysica acta.
[50] A. Sali,et al. Modeling of loops in protein structures , 2000, Protein science : a publication of the Protein Society.
[51] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[52] 3D Structure Model of the Principal Neutralizing Epitope of Minnesota HIV-1 Isolate , 2004, Journal of biomolecular structure & dynamics.
[53] Bette Korber,et al. Structure of a V3-Containing HIV-1 gp120 Core , 2005, Science.
[54] M. Rey-Cuillé,et al. N-linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection. , 2001, AIDS research and human retroviruses.
[55] R L Stanfield,et al. Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[56] M. Essex,et al. CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[57] S. Sherman,et al. Derivation of locally accurate spatial protein structure from NMR data. , 1993, Progress in biophysics and molecular biology.
[58] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[59] V. Veresov,et al. Structural Analysis of the HIV-1 gp120 V3 Loop: Application to the HIV-Haiti Isolates , 2007, Journal of biomolecular structure & dynamics.
[60] H. Schuitemaker,et al. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule , 1992, Journal of virology.